The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis

Marte A.M. van Hylckama Vlieg, Kazem Nasserinejad, Chantal Visser, Wichor M. Bramer, Aneel A. Ashrani, Jean-Luc Bosson, Daniel J. Crusan, Andrea D'Alessio, Meg E. Fluharty, Valdis Ģībietis, Per-Olof Hansson, Nobuhiro Hara, Luis Jara-Palomares, Noémie Kraaijpoel, Isabelle Mahé, Andrea Marshall, Yutaka Ogino, Remedios Otero, Jorie Versmissen, Frederikus A. Klok, Marieke J.H.A. Kruip, Carin C.D. van der Rijt, Eric C.T. Geijteman

Open source

DOI
10.1016/j.eclinm.2023.102194
Published
2023-10
Container
eClinicalMedicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2023.102194,
  title = {The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis},
  author = {Marte A.M. van Hylckama Vlieg and Kazem Nasserinejad and Chantal Visser and Wichor M. Bramer and Aneel A. Ashrani and Jean-Luc Bosson and Daniel J. Crusan and Andrea D'Alessio and Meg E. Fluharty and Valdis Ģībietis and Per-Olof Hansson and Nobuhiro Hara and Luis Jara-Palomares and Noémie Kraaijpoel and Isabelle Mahé and Andrea Marshall and Yutaka Ogino and Remedios Otero and Jorie Versmissen and Frederikus A. Klok and Marieke J.H.A. Kruip and Carin C.D. van der Rijt and Eric C.T. Geijteman},
  year = {2023},
  journal = {eClinicalMedicine},
  doi = {10.1016/j.eclinm.2023.102194},
  url = {https://doi.org/10.1016/j.eclinm.2023.102194}
}

RIS

TY  - JOUR
TI  - The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis
AU  - Marte A.M. van Hylckama Vlieg
AU  - Kazem Nasserinejad
AU  - Chantal Visser
AU  - Wichor M. Bramer
AU  - Aneel A. Ashrani
AU  - Jean-Luc Bosson
AU  - Daniel J. Crusan
AU  - Andrea D'Alessio
AU  - Meg E. Fluharty
AU  - Valdis Ģībietis
AU  - Per-Olof Hansson
AU  - Nobuhiro Hara
AU  - Luis Jara-Palomares
AU  - Noémie Kraaijpoel
AU  - Isabelle Mahé
AU  - Andrea Marshall
AU  - Yutaka Ogino
AU  - Remedios Otero
AU  - Jorie Versmissen
AU  - Frederikus A. Klok
AU  - Marieke J.H.A. Kruip
AU  - Carin C.D. van der Rijt
AU  - Eric C.T. Geijteman
PY  - 2023
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2023.102194
UR  - https://doi.org/10.1016/j.eclinm.2023.102194
ER  - 

APA

Vlieg, M. A. V. H., Nasserinejad, K., Visser, C., Bramer, W. M., Ashrani, A. A., Bosson, J., Crusan, D. J., D'Alessio, A., Fluharty, M. E., Ģībietis, V., Hansson, P., Hara, N., Jara-Palomares, L., Kraaijpoel, N., Mahé, I., Marshall, A., Ogino, Y., Otero, R., Versmissen, J., Klok, F. A., Kruip, M. J., Rijt, C. C. V. D., & Geijteman, E. C. (2023). The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2023.102194

Source records